E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection
Journal of Leukocyte Biology · 2024
DOI: 10.1093/jleuko/qiae019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Jaishree Sharma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, United States. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-cbl, Immunity, Innate, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Start-up funds, Department of Pathobiology, UIUC, NIH HHS.
Abstract (Originalsprache)
Nontuberculous mycobacteria (NTM) are emerging opportunistic pathogens causing pulmonary infection to fatal disseminated disease. NTM infections are steadily increasing in children and adults, and immune-compromised individuals are at a greater risk of fatal infections. The NTM disease's adverse pathology and resistance to antibiotics have further worsened the therapeutic measures. Innate immune regulators are potential targets for therapeutics to NTM, especially in a T cell–suppressed population, and many ubiquitin ligases modulate pathogenesis and innate immunity during infections, including mycobacterial infections. Here, we investigated the role of an E3 ubiquitin ligase, Casitas B-lineage lymphoma proto-oncogene B (CBLB), in immunocompromised mouse models of NTM infection. We found that CBLB is essential to prevent bacterial growth and dissemination. Cblb deficiency debilitated natural killer cells, inflammatory monocytes, and macrophages in vivo. However, Cblb deficiency in macrophages did not wane its ability to inhibit bacterial growth or production of reactive oxygen species or interferon γ production by natural killer cells in vitro. CBLB restricted NTM growth and dissemination by promoting early granuloma formation in vivo. Our study shows that CBLB bolsters innate immune responses and helps prevent the dissemination of NTM during compromised T cell immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, United States.
- Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, United States.
- Integrative Biology Honors Program, University Illinois at Urbana-Champaign, Urbana, IL 61801, United States.
- Veterinary Diagnostic Laboratory, University of Illinois at Urbana-Champaign, Urbana, IL 61802, United States.
Förderung
- NIAID NIH HHS
- Start-up funds, Department of Pathobiology, UIUC
- NIH HHS
- National Institutes of Health
Zitieren
APA
Sharma, J., Mudalagiriyappa, S., Abdelaal, H. F. M., Kelly, T. C., Choi, W., Ponnuraj, N., Vieson, M. D., Talaat, A. M., & Nanjappa, S. G. (2024). E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae019
Vancouver
Sharma J, Mudalagiriyappa S, Abdelaal HFM, Kelly TC, Choi W, Ponnuraj N, et al. E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae019
BibTeX
@article{Sharma2024,
author = {Sharma, Jaishree and Mudalagiriyappa, Srinivasu and Abdelaal, Hazem F M and Kelly, Thomas C and Choi, Woosuk and Ponnuraj, Nagendraprabhu and Vieson, Miranda D and Talaat, Adel M and Nanjappa, Som Gowda},
title = {E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection},
journal = {Journal of Leukocyte Biology},
year = {2024},
doi = {10.1093/jleuko/qiae019}
}
EUVIMED